EUVIMEDEUVIMED entdecken
Klinische Studie (Phase I)

Pharmacological and clinical profile of asciminib hydrochloride, a novel first-in-class tyrosine kinase inhibitor specifically targeting ABL myristoyl pocket

Jihye Chung, Taisuke Ariyoshi, Tomohiro Yoneda, Yusuke Kagawa, Yasunori Kawakita, Akio Maki

Folia Pharmacologica Japonica · 2023

DOI: 10.1254/fpj.22156 ↗

Kurz gefasst

Klinische Studie (Phase I) in der Zeitschrift Folia Pharmacologica Japonica, 2023. Verfasst von Jihye Chung und 5 weiteren Autor:innen. Beteiligte Einrichtung: Novartis Pharma KK, Medical Affairs Division. Hauptthemen laut MEDLINE: Antineoplastic Agents, Leukemia, Myelogenous, Chronic, BCR-ABL Positive. Die Arbeit nennt 25 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antineoplastic AgentsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHumansDrug Resistance, NeoplasmFusion Proteins, bcr-ablProtein Kinase InhibitorsPyrazolesTyrosine Kinase InhibitorsNiacinamide

Substanzen

Antineoplastic AgentsFusion Proteins, bcr-ablProtein Kinase InhibitorsPyrazolesTyrosine Kinase InhibitorsasciminibNiacinamide

Autor:innen und Institutionen

  • Novartis Pharma KK, Medical Affairs Division.
  • Novartis Pharma KK, Global Drug Development Division.

Zitieren

APA

Chung, J., Ariyoshi, T., Yoneda, T., Kagawa, Y., Kawakita, Y., & Maki, A. (2023). Pharmacological and clinical profile of asciminib hydrochloride, a novel first-in-class tyrosine kinase inhibitor specifically targeting ABL myristoyl pocket. Folia Pharmacologica Japonica. https://doi.org/10.1254/fpj.22156

Vancouver

Chung J, Ariyoshi T, Yoneda T, Kagawa Y, Kawakita Y, Maki A. Pharmacological and clinical profile of asciminib hydrochloride, a novel first-in-class tyrosine kinase inhibitor specifically targeting ABL myristoyl pocket. Folia Pharmacologica Japonica. 2023. doi:10.1254/fpj.22156

BibTeX
@article{Chung2023,
  author = {Chung, Jihye and Ariyoshi, Taisuke and Yoneda, Tomohiro and Kagawa, Yusuke and Kawakita, Yasunori and Maki, Akio},
  title = {Pharmacological and clinical profile of asciminib hydrochloride, a novel first-in-class tyrosine kinase inhibitor specifically targeting ABL myristoyl pocket},
  journal = {Folia Pharmacologica Japonica},
  year = {2023},
  doi = {10.1254/fpj.22156}
}
Kostenlos starten →